Nantahala Capital Management, LLC Soleno Therapeutics Inc Transaction History

Nantahala Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$0.22 - $0.47 $72,295 - $154,449	-328,617 Reduced 3.37%	9,436,512 $2.1 Million
Q2 2021 Aug 16, 2021	BUY	$0.97 - $1.32 $1.89 Million - $2.57 Million	1,948,400 Added 24.93%	9,765,129 $11.1 Million
Q1 2021 May 14, 2021	SELL	$1.24 - $3.3 $67,737 - $180,269	-54,627 Reduced 0.69%	7,816,729 $9.85 Million
Q4 2020 Feb 16, 2021	BUY	$1.61 - $2.23 $716,430 - $992,323	444,988 Added 5.99%	7,871,356 $15.2 Million
Q2 2020 Aug 14, 2020	BUY	$1.77 - $4.23 $5.57 Million - $13.3 Million	3,148,445 Added 73.6%	7,426,368 $16.5 Million
Q4 2019 Feb 14, 2020	BUY	$1.35 - $2.95 $5.78 Million - $12.6 Million	4,277,923 New	4,277,923 $12.6 Million

Ticker SLNO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 8,101,250
Market Cap $413M
Description
Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Controlled-Release, a once-daily oral tablet for the treatment of Prader-Willi Syndrome, which is being evaluated in an ongoing P...

Get notified when there are updates to the investment portfolio of Nantahala Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Nantahala Capital Management, LLC with notifications on news.